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Non-coding RNAs (ncRNAs), and in particular microRNAs
(miRNAs) are rapidly becoming the focus of research interest in
numerous basic and translational fields, and their importance for
many aspects in brain functioning reveals novel roles and mer-
its special discussion. The wide-scope, multi-targeted, and highly
efficient manner of ncRNA regulatory activities draws attention
to this topic by many, but the available research tools and exper-
imental protocols are still insufficient, and their importance for
many aspects in brain functioning keeps changing. Much of the
research effort in this field has initially been devoted to can-
cer research, but the regulatory role of ncRNAs is considered
global. Consequently, molecular neuroscientists picked it up as
well, although the brain presents special challenges for ncRNA
and miRNA research. To reflect the rapid recent development of
ncRNA and miRNA research in the nervous system, this Research
Topic eBook is focused on the search for and exploration of
those ncRNAs and miRNAs whose activities modulate the multi-
leveled functions of the eukaryotic brain in health and disease. It
strives to cover the state of the art expertise and describe novel
roles for known and recently identified ncRNAs and miRNAs
and cover experimental approaches for identifying and establish-
ing ncRNA-target relationships, reports of the affected pathways,
inherited and acquired changes in ncRNA functioning and the use
of ncRNA mimics and blockade tools for interference with their
functions in health and disease.
This eBook covers several key topics of interest in the molecu-
lar neuroscience field that try to bridge the gap between ncRNAs,
miRNAs, and the wider research community. As researchers, we
are interested in advancing this field for the improvement of both
basic and translational studies aimed at progressing toward better
human health and wellbeing. Therefore, this volume is opened by
a review contributed by the Gerhard Schratt group that presents a
comprehensive characterization of the nuclear miRNA repertoire
of post-mitotic neurons (Khudayberdiev et al., 2013). This is fol-
lowed by a thorough discussion of the flexibility and stability of
miRNAs in brain development and function that was written by
the Christophe Beclin group (Follert et al., 2014) and by insights
on the functional interactions betweenmiRNAs and copy number
variations in the aging brain contributed by the Ronald Bontrop
group (Persengiev et al., 2013). Yet other authors focused their
articles on particular neuronal roles of specific miRNAs. Thus,
Alexander Murashov and Di Wu described the role of miRNA-
431 in regulating axon regeneration in mature sensory neurons
by targeting the Wnt antagonist Kremen1 (Wu and Murashov,
2013), while Bettina Nadorp presented a new view of the dif-
ferent genes involved in specific neurotransmission pathways as
co-regulated by miRNAs (Nadorp and Soreq, 2014). To this
end, she initiated a bioinformatics effort combined with in vivo
experimental work to discover and validate the role of predicted
overlapping microRNA regulators of acetylcholine packaging and
degradation in neuroinflammation-related disorders.
Engineered animal models represent an important tool for
exploring ncRNA and miRNA functions in the brain, and sev-
eral of the articles in this eBook reflect this aspect. Some of the
covered research efforts took global experimental approaches in
diverse engineered animal models; thus, the Sebastian Kadener
group reported Genome-wide assessment of post-transcriptional
control in the fly brain, highlighting the rapid changes in this
dynamic field of research (Mezan et al., 2013). Yet others referred
to the diagnostic potential, like the Andre Fisher group that cov-
ered the rapidly evolving field of miRNA biomarkers for Central
Nervous System disease (Rao et al., 2013). Hartl and Grunwald-
Kadow and co-authors outlined new roles for “old” miRNAs
in nervous system functions and diseases (Hartl and Grunwald
Kadow, 2013). Another, even newer topic in this field is that of
long ncRNAs in neurodevelopmental disorders, a subject which
is likely to develop exponentially in the coming years and was
the focus of an article by the Armaz Aschrafi group (van de
Vondervoort et al., 2013).
The rapidly gained reputation of miRNAs lead to escalating
numbers of joint basic-clinical studies, and many of those put
a major emphasis on the nervous system diseases as related to
changes in miRNAs. The most prevalent neurodegenerative dis-
ease, Alzheimer’s disease was the focus of two separate articles:
Sebastian Hebert and colleagues discussed the future prospects of
circulating miRNAs to become a useful diagnostic tool and create
novel biomarkers for early identification of Alzheimer’s disease
(Dorval et al., 2013), whereas the Euginia Wang group presented
an in-depth study of the prospects of one specific miRNA to
become such a biomarker (Bhatnagar et al., 2014): miRNA-34c,
which was previously shown to associate with aging and whose
levels are shown in our eBook to increase in the Alzheimer’s cir-
culating plasma. The next two articles shift the interest to nervous
system diseases affecting younger patients, like chronic pain and
epilepsy. Here, Michaela Kress and co-authors address the topics
of pain regulation by miRNAs in nociceptive circuits as predictors
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of future clinical applications (Kress et al., 2013), and David
Henshall covers the issue of miRNAs involvement in status epilep-
ticus (Henshall, 2013). A key issue inmiRNA research involves the
emerging need to combine experimental work with state of the
art biostatistics and bioinformatics analyses. Combined bioinfor-
matics/genetics and miRNA studies appear in theMarkus Nothen
review of the highly focused role of miRNAs as the cause of
schizophrenia in those rare patients who are 22q11.2 deletion
carriers, and this study was expanded to discuss the possible
implications for idiopathic disease at large (Forstner et al., 2013).
MiRNAs in sensorineural diseases of the ear were the focus of
a mini-review by the Karen Avraham group, and may be per-
ceived as a first sign of new discoveries on miRNA contributions
in sensory impairments (Ushakov et al., 2013). Ischemic stroke
is another nervous system disease with an expanding impact in
these days of continuously prolonged life expectancy in Western
societies. In our eBook, Julie Anne Saugstad and co-workers dis-
cuss modified miRNAs following focal cerebral ischemia in male
and female mouse brains (Lusardi et al., 2014).
Apart from the miRNAs themselves, our eBook also refers to
the protein complexes involved in miRNA functioning, also in
the context of neurodegenerative disease. The RISC complex and
its causal involvement in Parkinson’s disease is the focus of an
article by the Matthew Wood group (Heman-Ackah et al., 2013).
Last, but not least are expanded repeat diseases that were cov-
ered by two independent studies: RNA pathogenesis via Toll-like
receptor-activated inflammation in expanded repeat neurodegen-
erative diseases by the Catherine Suter group (Richards et al.,
2013) and Small ncRNAs as source of complexity added to the
RNA pathogenic mechanisms in trinucleotide repeat expansion
diseases (Marti and Estivill, 2013). ncRNAs are here to stay,
and their impact on our brain’s functioning at the physiology,
cell biology, behavior, and immune levels is worth an in-depth
journey.
REFERENCES
Bhatnagar, S., Chertkow, H., Schipper, H. M., Yuan, Z., Shetty, V., Jenkins, S.,
et al. (2014). Increased microRNA-34c abundance in Alzheimer’s disease cir-
culating blood plasma. Front. Mol. Neurosci. 7:2. doi: 10.3389/fnmol.2014.
00002
Dorval, V., Nelson, P. T., and Hebert, S. S. (2013). Circulating microRNAs in
Alzheimer’s disease: the search for novel biomarkers. Front. Mol. Neurosci. 6:24.
doi: 10.3389/fnmol.2013.00024.
Follert, P., Cremer, H., and Beclin, C. (2014). MicroRNAs in brain development
and function: a matter of flexibility and stability. Front. Mol. Neurosci. 7:5. doi:
10.3389/fnmol.2014.00005
Forstner, A. J., Degenhardt, F., Schratt, G., and Nothen, M. M. (2013). MicroRNAs
as the cause of schizophrenia in 22q11.2 deletion carriers, and possible impli-
cations for idiopathic disease: a mini-review. Front. Mol. Neurosci. 6:47. doi:
10.3389/fnmol.2013.00047
Hartl, M., and Grunwald Kadow, I. C. (2013). New roles for old microR-
NAs in nervous system function and disease. Front. Mol. Neurosci. 6:51. doi:
10.3389/fnmol.2013.00051
Heman-Ackah, S. M., Hallegger, M., Rao, M. S., and Wood, M. J. (2013). RISC
in PD: the impact of microRNAs in Parkinson’s disease cellular and molecular
pathogenesis. Front. Mol. Neurosci. 6:40. doi: 10.3389/fnmol.2013.00040
Henshall, D. C. (2013). MicroRNAs in the pathophysiology and treatment of status
epilepticus. Front. Mol. Neurosci. 6:37. doi: 10.3389/fnmol.2013.00037
Khudayberdiev, S. A., Zampa, F., Rajman, M., and Schratt, G. (2013). A compre-
hensive characterization of the nuclear microRNA repertoire of post-mitotic
neurons. Front. Mol. Neurosci. 6:43. doi: 10.3389/fnmol.2013.00043
Kress, M., Huttenhofer, A., Landry, M., Kuner, R., Favereaux, A., Greenberg, D.,
et al. (2013). microRNAs in nociceptive circuits as predictors of future clinical
applications. Front. Mol. Neurosci. 6:33. doi: 10.3389/fnmol.2013.00033
Lusardi, T. A., Murphy, S. J., Phillips, J. I., Chen, Y., Davis, C. M., Young, J. M.,
et al. (2014). MicroRNA responses to focal cerebral ischemia in male and female
mouse brain. Front. Mol. Neurosci. 7:11. doi: 10.3389/fnmol.2014.00011
Marti, E., and Estivill, X. (2013). Small non-coding RNAs add complexity to the
RNA pathogenic mechanisms in trinucleotide repeat expansion diseases. Front.
Mol. Neurosci. 6:45. doi: 10.3389/fnmol.2013.00045
Mezan, S., Ashwal-Fluss, R., Shenhav, R., Garber, M., and Kadener, S. (2013).
Genome-wide assessment of post-transcriptional control in the fly brain. Front.
Mol. Neurosci. 6:49. doi: 10.3389/fnmol.2013.00049
Nadorp, B., and Soreq, H. (2014). Predicted overlapping microRNA regulators of
acetylcholine packaging and degradation in neuroinflammation-related disor-
ders. Front. Mol. Neurosci. 7:9. doi: 10.3389/fnmol.2014.00009
Persengiev, S., Kondova, I., and Bontrop, R. (2013). Insights on the functional inter-
actions between miRNAs and copy number variations in the aging brain. Front.
Mol. Neurosci. 6:32. doi: 10.3389/fnmol.2013.00032
Rao, P., Benito, E., and Fischer, A. (2013). MicroRNAs as biomarkers for CNS
disease. Front. Mol. Neurosci. 6:39. doi: 10.3389/fnmol.2013.00039
Richards, R. I., Samaraweera, S. E., van Eyk, C. L., O’Keefe, L. V., and Suter, C.
M. (2013). RNA pathogenesis via Toll-like receptor-activated inflammation in
expanded repeat neurodegenerative diseases. Front. Mol. Neurosci. 6:25. doi:
10.3389/fnmol.2013.00025
Ushakov, K., Rudnicki, A., and Avraham, K. B. (2013). MicroRNAs in sensorineural
diseases of the ear. Front. Mol. Neurosci. 6:52. doi: 10.3389/fnmol.2013.00052
van de Vondervoort, I. I., Gordebeke, P. M., Khoshab, N., Tiesinga, P. H., Buitelaar,
J. K., Kozicz, T., et al. (2013). Long non-coding RNAs in neurodevelopmental
disorders. Front. Mol. Neurosci. 6:53. doi: 10.3389/fnmol.2013.00053
Wu, D., and Murashov, A. K. (2013). MicroRNA-431 regulates axon regeneration
in mature sensory neurons by targeting the Wnt antagonist Kremen1. Front.
Mol. Neurosci. 6:35. doi: 10.3389/fnmol.2013.00035
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 08 May 2014; accepted: 30 May 2014; published online: 26 June 2014.
Citation: Soreq H (2014) Novel roles of non-coding brain RNAs in health and disease.
Front. Mol. Neurosci. 7:55. doi: 10.3389/fnmol.2014.00055
This article was submitted to the journal Frontiers in Molecular Neuroscience.
Copyright © 2014 Soreq. This is an open-access article distributed under the terms of
the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Molecular Neuroscience www.frontiersin.org June 2014 | Volume 7 | Article 55 | 2
